Benefit-Risk Assessment of mRNA COVID-19 Vaccines in Children Aged 6 Months to 4 Years in the Omicron Era. - Kitano T; Salmon DA; Dudley MZ; Thompson DA; Engineer L (Journal of the Pediatric Infectious Diseases Society, 2024)